Huntington Bancshares (HBAN)
NASDAQFinancialsBanks - RegionalSnapshot 2026-10-30
NASDAQFinancialsBanks - RegionalSnapshot 2026-10-30
Research Workspace
Put HBAN beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Regional Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 20% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMostly healthy — no soft spokes
HBAN’s case rests on steady financial performance, though recent revenue growth has slowed. Q3 2026 revenue grew 31% year over year, and non-GAAP EPS was inline. The shares trade at 1.0× P/B versus the 1.2× peer median. The price reflects less growth than our forecast, despite recent guidance cuts. Our model puts the next-quarter miss probability near 17%. Peer multiples imply a price about 8% above where it trades; our read remains intact. This read is provisional.
Trailing returns as of 2026-10-30. HBAN is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering HBAN (as of Oct 2026).
Based on 8 Wall Street analysts offering 12-month price targets for HBAN in the last 4 months.
Continue this research
Compare HBAN with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| HBAN Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Regional Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put HBAN next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Price target cut indicates weaker growth expectations.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $15.78
The last 12 months of price, then the range of analyst 12-month targets from today’s $15.78.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Threatens: Drive strong organic growth
Cuts outlook indicates challenges in driving organic growth.

Threatens: Maintain dividend at $0.155 per share
Lower earnings guidance impacts dividend sustainability.

Increased loan competition may hinder organic growth.

Lowered guidance outlook indicates potential growth challenges.

Advances: Complete integration and realize synergies from acquisitions
New CEO aligns with growth and integration objectives.

Advances: Drive strong organic growth
Details on achieving ROTCE target align with growth objectives.
Threatens: Drive strong organic growth
Mixed credit signals indicate potential growth challenges.